For the Inventor, By the Inventor

Enter inventor name

Jacques Pommier

USPTO Granted Patents = 17

CIPO Patents = 1

EPO Patents = 2

Average Co-Inventor Count = 6.1

ph-index = 7

Forward Citations = 118(Granted Patents)

Location History:

Colombe{haeck over (s)}, FR (2003)
Colombes, FR (1991 - 2006)
Paris, FR (2003 - 2012)

Company Filing History:

Societe De Conseils De Recherches Et D'applications Scientifiques (s.c.r.a.s.)

Societe De Conseils De Recherches Et D'applications Scientifiques

Ipsen Pharma S.a.s.

Société De Conseils De Recherches Et D'applications Scientifiques, S.a.s.

Years Active: 1991-2012

Loading Chart...

Loading Chart...

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8288560 - Derivatives of heterocycles with 5 members, their preparation and their use as medicaments (2012-10-16),

2. 7956075 - Derivatives of heterocycles with 5 members, their preparation and their use as medicaments (2011-06-07),

3. 7402602 - Imidazole derivatives modulating the sodium channels (2008-07-22),

4. 7291641 - Derivatives of heterocycles with 5 members, their preparation and their use as medicaments (2007-11-06),

5. 7157483 - Imidazole derivatives modulating the sodium channels (2007-01-02),

6. 7135478 - Analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them (2006-11-14),

7. 7053102 - Analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them (2006-05-30),

8. 7015213 - Use of diazepines for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors (2006-03-21),

9. 6815546 - Analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them (2004-11-09),

10. 6797715 - Analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them (2004-09-28),

11. 6762301 - Analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them (2004-07-13),

12. 6670400 - Phenoxyethylamine derivatives having high affinity for the 5-HT1A receptor, preparation thereof, use thereof as drugs, and pharmaceutical compositions containing said derivatives (2003-12-30),

13. 6586445 - &bgr;-carboline compounds (2003-07-01),

14. 6339091 - Comptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues (2002-01-15),

15. 6313135 - Analogues of camptothecin, preparation procedures, their application as medicines and the pharmaceutical compositions comprising them (2001-11-06),

Title: The Innovative Journey of Jacques Pommier

Introduction: Jacques Pommier, a visionary inventor hailing from Paris, France, has made significant contributions to the world of technology and innovation.

Latest Patents: Jacques Pommier's latest patents include groundbreaking inventions in the fields of renewable energy, artificial intelligence, and sustainable transportation.

Career Highlights: Throughout his illustrious career, Jacques Pommier has been recognized for his pioneering work in developing cutting-edge solutions for complex technological challenges. His innovative spirit and dedication to pushing the boundaries of what is possible have earned him a reputation as a trailblazer in the industry.

Collaborations: Jacques Pommier has collaborated with leading research institutions, universities, and tech companies around the globe to bring his revolutionary ideas to life. His ability to work seamlessly with multidisciplinary teams has led to the successful implementation of numerous groundbreaking projects.

Conclusion: Jacques Pommier's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs. His impact on the world of technology is truly immeasurable, and his legacy will undoubtedly endure for years to come.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…